Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cells

Fertility and Sterility

Volumn 69, Issue 2, 1998, Pages 335-340

  Duleba, Antoni J ^a   Spaczynski, Robert Z ^a   Olive, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IGF I; Insulin; Proliferation; Theca interstitial cells

Indexed keywords

INSULIN; SOMATOMEDIN C;

ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RESISTANCE; LEYDIG CELL; MITOSIS INDEX; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PRIORITY JOURNAL; STROMA CELL; THECA CELL;

ADULT; CELL DIVISION; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; OSMOLAR CONCENTRATION; OVARY; STROMAL CELLS; THECA CELLS; THYMIDINE; TRITIUM;

EID: 0031906426     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00473-1     Document Type: Article

References (25)

1. Barbiert RL. Polycystic ovarian disease. Annu Rev Med 1991;42:199-204.
2. Hughesdon PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so called "hyperthecosis". Obstet Gynecol Surv 1982;37:59-77.
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74.
4. Iwashita M, Mimuro T, Watanabe M, Setoyama T, Matsuo A, Adachi T, et al. Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome. Horm Res 1990;33:21-6.
5. Homburg R, Pariente C, Lunenfeld B, Jacobs HS. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod 1992;7:1379-83.
6. San Roman GA, Magoffin DA. Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J Clin Endocrinol Metab 1992;75:1010-6.
7. Wild RA, Applebaum-Bowden D, Demers LM, Bartholomew M, Landis JR, Hazzard WR, et al. Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgens. Clin Chem 1990;36:283-9.
8. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Acta Obstet Gynecol Scand 1992;71:599-604.
9. Poretsky L, Bhargava G, Kalin MF, Wolf SA. Regulation of insulin receptors in the human ovary: in vitro studies. J Clin Endocrinol Metab 1988;67:774-8.
10. Poretsky L, Bhargava G, Levitan E. Type I insulin-like growth factor receptors in human ovarian stroma. Horm Res 1990;33:22-6.
11. El-Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts CT Jr, Yen SS. Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab 1993;77:1411-8.
12. Barbieri RL, Makris A, Ryan KJ. Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet Gynecol 1984;64:73S-80S.
13. Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988;123:733-9.
14. Duleba AJ, Spaczynski RZ, Olive DL, Behrman HR. Effects of insulin and insulin-like growth factors on proliferation of rat ovarian thecainterstitial cells. Biol Reprod 1997;56:891-7.
15. Magoffin DA, Erickson GF. An improved method for primary culture of ovarian androgen-producing cells in serum-free medium: effect of lipoproteins, insulin, and insulinlike growth factor-I. In Vitro Cell Dev Biol 1988;24:862-70.
16. Khan-Dawood FS, Yusoff Dawood M, Tabibzadeh S. Immunohistochemical analysis of the microanatomy of primate ovary. Biol Reprod 1996;54:734-42.
17. Smith CP, Dunger DB, Williams AJ, Taylor AM, Perry LA, Gale EA, et al. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab 1989;68:932-7.
18. Dewailly D, Robert Y, Helin I, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L, et al. Ovarian stromal hypertrophy in hyperandrogenic women. Clin Endocrinol 1994;41:557-62.
19. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 1976;294:739-45.
20. Norman RJ, Hague WM, Masters SC, Wang XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 1995;10:2258-61.
21. Smith S, Ravnikar VA, Barbieri RL. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil Steril 1987;48:72-7.
22. Tiitinen AE, Laatikainen TJ, Seppala MT. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease. Fertil Steril 1993;60:58-62.
23. Oliver JE, Aitman TJ, Powell JF, Wilson CA, Clayton RN. Insulin-like growth factor I gene expression in the rat ovary is confined to the granulosa cells of developing follicles. Endocrinology 1989;124:2671-9.
24. Najmabadi S, Wilcox JG, Accacio BD, Thornton MH, Kolb BA, Paulson RJ. The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome. Fertil Steril 1997;67:631-5.
25. Magoffin DA, Weitsman SR. Insulin-like growth factor-I stimulates the expression of 3β-hydroxysteroid dehydrogenase messenger ribonucleic acid in ovarian theca-interstitial cells. Biol Reprod 1993;48:1166-73.